B

    Boston Scientific Corp (BSX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $48.30
    +1.45 (+3.11%)

    Market Cap: $67.88B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    85%(34/40)
    Avg Surprise
    +16.81%
    Streak
    14 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.81
    Range$0.80 - $0.84
    23 analysts
    EPS RevisionsNo revisions (7d)
    0
    21
    30d
    EPS Estimate Drift
    90d ago$0.84+4.5%
    60d ago$0.84+4.1%
    30d ago$0.84+4.1%
    7d ago$0.81+0.0%
    Current$0.81
    Revenue Consensus
    $5.3B
    Range$5.2B - $5.3B
    24 analysts
    Dec 31, 2026
    EPS Consensus$0.88
    Range$0.86 - $0.95
    26 analysts
    Revenue Consensus
    $5.6B
    Range$5.3B - $6.3B
    28 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.88---
    Sep 26EST
    		-$0.81---
    Jun 26
    		$0.86$0.83+3.61%Beat+14.7%
    Mar 26
    		$0.80$0.79+1.27%Beat+6.7%
    Dec 25
    		$0.80$0.78+2.56%Beat+14.3%
    Sep 25
    		$0.75$0.71+5.63%Beat+19.0%
    Jun 25
    		$0.75$0.73+2.74%Beat+21.0%
    Mar 25
    		$0.75$0.67+11.94%Beat+33.9%
    Dec 24
    		$0.70$0.66+6.06%Beat+27.3%
    Sep 24
    		$0.63$0.59+6.78%Beat+26.0%
    Jun 24
    		$0.62$0.58+6.90%Beat+17.0%
    Mar 24
    		$0.56$0.51+9.80%Beat+19.1%
    Dec 23
    		$0.55$0.51+7.84%Beat+22.2%
    Sep 23
    		$0.50$0.48+4.17%Beat+16.3%
    Jun 23
    		$0.53$0.49+8.16%Beat+20.5%
    Mar 23
    		$0.47$0.43+9.30%Beat+20.5%
    Dec 22
    		$0.45$0.47-4.26%Miss+0.0%
    Sep 22
    		$0.43$0.44-2.27%Miss+4.9%
    Jun 22
    		$0.44$0.42+4.76%Beat+10.0%
    Mar 22
    		$0.39$0.39+0.00%Beat+5.4%
    Dec 21
    		$0.45$0.44+2.27%Beat+95.7%
    Sep 21
    		$0.41$0.40+2.50%Beat+10.8%
    Jun 21
    		$0.40$0.37+8.11%Beat+400.0%
    Mar 21
    		$0.37$0.31+19.35%Beat+32.1%
    Dec 20
    		$0.23$0.31-25.81%Miss-50.0%
    Sep 20
    		$0.37$0.25+48.00%Beat-5.1%
    Jun 20
    		$0.08$-0.02+500.00%Beat-79.5%
    Mar 20
    		$0.28$0.32-12.50%Miss-20.0%
    Dec 19
    		$0.46$0.44+4.55%Beat+17.9%
    Sep 19
    		$0.39$0.38+2.63%Beat+11.4%
    Jun 19
    		$0.39$0.38+2.63%Beat-4.9%
    Mar 19
    		$0.35$0.36-2.78%Miss+6.1%
    Dec 18
    		$0.39$0.36+8.33%Beat+14.7%
    Sep 18
    		$0.35$0.34+2.94%Beat+12.9%
    Jun 18
    		$0.41$0.34+20.59%Beat+28.1%
    Mar 18
    		$0.33$0.32+3.13%Beat+13.8%
    Dec 17
    		$0.34$0.34+0.00%Beat+13.3%
    Sep 17
    		$0.31$0.31+0.00%Beat+14.8%
    Jun 17
    		$0.32$0.31+3.23%Beat-
    Mar 17
    		$0.29$0.30-3.33%Miss-
    Dec 16
    		$0.30$0.29+3.45%Beat-
    Sep 16
    		$0.27$0.27+0.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio15.05EV/EBITDA14.14x
    Price/FCF19.59xFCF Yield5.11%
    Profitability
    Profit Margin17.50%Operating Margin22.90%
    ROE15.30%ROIC10.68%
    Financial Health
    Debt/Equity0.51xInterest Coverage11.63x
    Current Ratio1.24xQuick Ratio0.74x
    Trading Statistics
    Beta0.57Avg Volume19.40M
    52-Week High$109.5052-Week Low$42.20

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$49.11
    SMA 20$49.73
    SMA 50$46.63
    SMA 200$67.87
    EMA 10$48.67
    EMA 20$48.74
    EMA 50$48.78
    EMA 200$64.05

    MACD

    Line: 0.22Signal: 0.74Hist: -0.52

    ADX

    ADX: 16.3+DI: 18.9-DI: 20.5

    Aroon & PSAR

    Aroon Up56.0
    Aroon Down8.0
    PSAR$49.98

    Bollinger Bands

    Upper Band$52.98
    Lower Band$46.47
    %B Position1310%(Upper)
    Band Width0.28

    RSI (14-Day)

    Neutral
    49.1

    Momentum Oscillators

    Stoch %K12.7
    Stoch %D12.9
    Williams %R-68.2
    ROC (10d)-6.1%
    Momentum-3.13
    CCI (20d)-98.9
    MFI (14d)37.8

    Volatility Measures

    ATR (14d)$1.79(3.7%)
    StdDev (20d)1.63
    Hist Vol38.7%(Moderate)

    Volume Flow

    VWAP$47.79
    OBV-366.4M
    AD Line-368.9M
    CMF (20d)0.007

    Volume Metrics

    Avg Vol (20d)19.3M
    Vol Ratio1.0x
    VWMA (20d)$49.65

    Pivot Points

    R3$47.93
    R2$47.57
    R1$47.21
    Pivot Point$46.85
    S1$46.49
    S2$46.13
    S3$45.77

    Advanced Oscillators

    TSI4.12
    Ultimate Osc49.7
    KST81.94

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$5.44B$5.20B$5.29B$5.07B$5.06B$4.66B$4.56B$4.21B$4.12B$3.86B$3.73B$3.53B
    Cost of Revenue$1.59B$1.59B$1.61B$1.52B$1.64B$1.45B$1.47B$1.31B$1.27B$1.21B$1.15B$1.10B
    Gross Profit$3.85B$3.61B$3.68B$3.54B$3.42B$3.21B$3.10B$2.90B$2.85B$2.65B$2.58B$2.43B
    Operating Expenses$2.67B$2.51B$2.85B$2.49B$2.60B$2.29B$2.42B$2.16B$2.33B$1.97B$2.00B$1.73B
    R&D$554.00M$516.00M$569.00M$514.00M$526.00M$443.00M$459.00M$407.00M$383.00M$366.00M$362.00M$356.00M
    SG&A$1.80B$1.78B$1.83B$1.74B$1.72B$1.60B$1.61B$1.56B$1.45B$1.36B$1.38B$1.24B
    Operating Income$1.18B$1.10B$825.00M$1.05B$819.00M$921.00M$675.00M$733.00M$520.00M$675.00M$584.00M$693.00M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$96.00M$90.00M$90.00M$87.00M$90.00M$82.00M$80.00M$79.00M$77.00M$69.00M$64.00M$66.00M
    Income Before Tax$1.06B$1.16B$700.00M$939.00M$941.00M$805.00M$585.00M$669.00M$420.00M$608.00M$505.00M$610.00M
    Income Tax Expense$155.00M$-176,000,000$31.00M$183.00M$146.00M$133.00M$23.00M$200.00M$98.00M$115.00M$1.00M$105.00M
    Net Income$905.00M$1.34B$670.00M$755.00M$795.00M$672.00M$563.00M$468.00M$322.00M$493.00M$504.00M$504.00M
    EBITDA$1.51B$1.60B$1.16B$1.38B$1.41B$1.29B$1.06B$1.05B$808.00M$981.00M$883.00M$978.00M
    EBIT$1.16B$1.25B$790.00M$1.02B$1.03B$887.00M$666.00M$747.00M$497.00M$677.00M$570.00M$675.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BSX

    Government Contracts

    Gov Obligations (TTM)
    $23.78M
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    -14.1%
    Active Awards
    1,471
    New Awards (TTM)
    1,409
    Avg Remaining Term
    8.5 mo

    Top agency: Department of Defense at 61.2% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C26126N0005Department of Veterans AffairsDepartment of Veterans Affairs$954240Oct 1, 2025
    36C26126F0019Department of Veterans AffairsDepartment of Veterans Affairs$821898Oct 1, 2025
    36C26226N0239Department of Veterans AffairsDepartment of Veterans Affairs$693000Jan 1, 2026
    36C25226N0450Department of Veterans AffairsDepartment of Veterans Affairs$607804Jul 15, 2026
    36C25026N0158Department of Veterans AffairsDepartment of Veterans Affairs$600601Nov 4, 2025
    W81K0025PA252Department of DefenseDepartment of the Army$552770Oct 1, 2025
    36C24626N0477Department of Veterans AffairsDepartment of Veterans Affairs$518712Feb 12, 2026
    36C25626N0278Department of Veterans AffairsDepartment of Veterans Affairs$518712Jan 1, 2026
    SPE2D626F4E8HDepartment of DefenseDefense Logistics Agency$445800Apr 23, 2026
    36C25226N0083Department of Veterans AffairsDepartment of Veterans Affairs$436810Oct 1, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Boston Scientific discloses 'global disruption' in ongoing cyberattack

    Medical device maker Boston Scientific has reported a "global disruption" to its operations due to an ongoing cyberattack that began on Tuesday. The incident has affected its IT systems, limiting access to information systems and business applications, and impacting its ability to process and ship customer orders. The company is investigating with third-party experts, but currently has no timeline for full restoration, and the full extent of operational and financial impacts remains unknown, causing its shares to drop.

    The Register•8/26/26•
    Bearish

    Boston Scientific says cyberattack disrupted order processing, shipping

    Boston Scientific is currently investigating a cyberattack from August 25, 2026, which has disrupted its global operations, including customer order processing and shipping. The medical device manufacturer has activated its incident response plan and is working with cybersecurity experts, though it cannot yet determine the financial or operational impact. Thousands of employees in Ireland have been told to work from home following the attack.

    Cybersecurity Dive•8/26/26•
    Somewhat-Bearish

    Boston Scientific Targeted in Cyberattack

    Boston Scientific is currently working to restore its systems after a cyberattack on August 25 caused a network outage and disrupted business operations, including the ability to process and ship customer orders. The company is investigating the incident with third-party cybersecurity experts. This

    Medical Product Outsourcing•8/26/26•
    Bearish

    Boston Scientific says a cyberattack is disrupting its global operations

    Medical device maker Boston Scientific announced that a cyberattack has disrupted its global operations, affecting systems for processing and shipping customer orders. The company is working with cybersecurity experts to contain the threat and restore systems, though the timeline for full restoration is unknown. Boston Scientific's shares fell following the news, highlighting the vulnerability of the healthcare sector to cyberattacks.

    Yahoo Finance•8/26/26•
    Bearish

    Agilent earnings up next as investors eye margin protection By Investing.com

    Agilent Technologies Inc. is set to release its fiscal third-quarter results, with investors keenly focused on whether the company can maintain its previously raised revenue guidance and protect its operating margins. Analysts expect earnings of $1.49 per share on revenue of $1.84 billion, and the stock currently holds a "Moderate Buy" consensus. Key areas of investor scrutiny include the impact of tariff-driven costs, product cycle momentum, and pharmaceutical/biotech customer spending patterns.

    Investing.com•8/26/26•
    Neutral

    Frequently Asked Questions About BSX

    Does BSX pay dividends?
    Boston Scientific Corp (BSX) does not currently pay a regular dividend.
    What is BSX's P/E ratio?
    Boston Scientific Corp has a price-to-earnings (P/E) ratio of 15.05.
    What is BSX's market cap?
    Boston Scientific Corp (BSX) has a market capitalization of $67.88B with a current stock price of $48.30.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In